| CEO Name | Pascal Soriot |
| Nationality | France |
| Net Worth Estimation | $40 million |
Pascal Soriot's estimated net worth of $40 million primarily stems from his long tenure as CEO of AstraZeneca plc, earning substantial annual compensation packages, stock awards, and performance bonuses. Additional wealth is attributed to accrued share options, investments, and prior executive roles at global pharmaceutical companies.
Pascal Soriot's estimated net worth of $40 million is 40% of the maximum and 400% of the minimum CEO net worth in the healthcare business category. His net worth positions him in the mid-upper range among peers with estimated values between $10 million and $90 million.
Business Category: Healthcare
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD
Pascal Soriot Performance in AstraZeneca plc
Pascal Soriot, CEO of AstraZeneca plc, demonstrates strategic leadership by driving innovation and global expansion, particularly in oncology and COVID-19 vaccine development. His decisive actions in portfolio prioritization and R&D investment have significantly improved company performance and market valuation. Under Soriot, AstraZeneca achieved robust revenue growth and strengthened its position as a leading biopharmaceutical firm.
Latest News
AstraZeneca CEO Pascal Soriot clinched a drug price deal with President Trump, agreeing to lower prescription costs for Medicaid, which Trump described as cutting prices to "the lowest price anywhere in the world." Soriot's reaction at the press conference went viral for its unusual expression, and he also discussed AstraZeneca's plans for US growth and direct medicine sales to patients.
http://www.hindustantimes.com/world-news/pascal-soriot-astrazeneca-ceos-bizarre-expression-at-trumps-presser-viral-trying-to-control-watch-101760138710537.html
Source: